article Open AccessTop 1% cited
Cholangiocarcinoma
Annals of Surgery · 1996 · Vol. 224(4) · pp. 463–475
Attila Nakeeb✉(Johns Hopkins University)Henry A. Pitt(Johns Hopkins University)Taylor A. Sohn(Johns Hopkins University)JoAnn Coleman(Johns Hopkins University)Ross A. Abrams(Johns Hopkins University)Steven Piantadosi(Johns Hopkins University)Ralph H. Hruban(Johns Hopkins University)Keith D. Lillemoe(Johns Hopkins University)Charles J. Yeo(Johns Hopkins University)John L. Cameron(Johns Hopkins University)
Abstract
Cholangiocarcinoma is best classified into three broad categories. Resection remains the primary treatment, whereas postoperative adjuvant radiation has no influence on survival. Therefore, new agents or strategies to deliver adjuvant therapy are needed to improve survival.
Cholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersViral-associated cancers and disordersMedicineIntrahepatic CholangiocarcinomaHazard ratioKlatskin tumorSurvival rateMultivariate analysisAbdominal painRadiologyGastroenterologyResection
MeSH terms
Bile Duct NeoplasmsBile Ducts, IntrahepaticFemaleHumansMaleMiddle AgedSurvival RateCholangiocarcinoma
Citations
1,171
FWCI
16.04
field-weighted impact
References
30
Percentile
99%
vs. same field & year
Citations per year
Cited by
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
Annals of Surgery · 2001 · 1,354 citations
Cholangiocarcinoma
Annals of Surgery · 2007 · 1,280 citations
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Journal of Hepatology · 2014 · 1,526 citations
Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s
Annals of Surgery · 1997 · 1,782 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.